KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $4.03 $5.34 Friday, 26th Apr 2024 BCRX stock ended at $4.16. During the day the stock fluctuated 3.40% from a day low at $4.12 to a day high of $4.26.
90 days $4.03 $6.35
52 weeks $4.03 $9.07

Historical BioCryst Pharmaceuticals prices

Date Open High Low Close Volume
Jan 14, 2021 $8.19 $8.68 $8.12 $8.59 5 091 159
Jan 13, 2021 $8.06 $8.41 $7.90 $8.15 4 580 635
Jan 12, 2021 $7.65 $8.25 $7.55 $8.04 4 942 123
Jan 11, 2021 $7.70 $7.75 $7.45 $7.51 3 913 195
Jan 08, 2021 $7.83 $8.00 $7.58 $7.74 3 945 474
Jan 07, 2021 $7.76 $7.89 $7.53 $7.74 3 840 036
Jan 06, 2021 $7.39 $7.79 $7.36 $7.55 5 271 192
Jan 05, 2021 $7.35 $7.46 $7.27 $7.37 3 263 695
Jan 04, 2021 $7.48 $7.70 $7.28 $7.38 3 757 141
Dec 31, 2020 $7.54 $7.56 $7.31 $7.45 3 421 456
Dec 30, 2020 $7.11 $7.65 $7.06 $7.50 5 839 028
Dec 29, 2020 $7.10 $7.28 $6.88 $7.04 5 819 970
Dec 28, 2020 $7.29 $7.49 $7.07 $7.18 4 561 176
Dec 24, 2020 $7.57 $7.62 $7.22 $7.28 2 840 832
Dec 23, 2020 $7.40 $7.66 $7.17 $7.56 5 719 236
Dec 22, 2020 $7.50 $7.93 $6.83 $7.59 18 132 421
Dec 21, 2020 $8.66 $8.73 $8.19 $8.30 7 830 752
Dec 18, 2020 $8.12 $8.61 $8.09 $8.61 16 746 161
Dec 17, 2020 $8.17 $8.34 $7.91 $8.20 7 211 716
Dec 16, 2020 $8.45 $8.61 $8.17 $8.29 5 284 899
Dec 15, 2020 $8.57 $8.59 $8.14 $8.31 6 022 104
Dec 14, 2020 $8.77 $8.99 $8.40 $8.50 10 837 953
Dec 11, 2020 $7.56 $8.45 $7.56 $8.12 8 296 543
Dec 10, 2020 $6.92 $7.70 $6.86 $7.65 8 212 098
Dec 09, 2020 $7.69 $7.73 $7.00 $7.26 11 494 078
Click to get the best stock tips daily for free!

About BioCryst Pharmaceuticals

BioCryst Pharmaceuticals BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX9930, an oral factor D inhibitor, which is in Phase II... BCRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT